Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLVS | AMGN | GILD | VRTX | REGN |
Company | Clovis Oncology Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 0.0808 | 265.72 | 65.50 | 393.52 | 881.72 |
High | 0.0977 | 270.77 | 66.35 | 395.90 | 884.99 |
Low | 0.0766 | 265.72 | 65.05 | 393.49 | 875.30 |
Last | 0.0812 | 270.50 | 64.82 | 395.82 | 882.49 |
Change | -0.0048 | +1.12 | -0.45 | -1.88 | -8.19 |
% Change | -5.58% | +0.42% | -0.69% | -0.47% | -0.92% |
Volume | 24,516,400 | 120,192 | 1,798,348 | 46,312 | 54,189 |
20-Day Average Volume | 9,433,500 | 2,037,964 | 6,522,095 | 911,200 | 433,229 |
Previous Close | 0.0860 | 269.38 | 65.27 | 397.70 | 890.68 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.2340 | 269.95 | 68.29 | 401.14 | 918.37 |
20-Day Raw Stochastic | 1.73% | 37.28% | 2.82% | 11.73% | 3.14% |
20-Day Relative Strength | 23.83% | 44.77% | 28.38% | 40.61% | 32.28% |
Weighted Alpha | -91.19 | +9.09 | -23.72 | +13.62 | +9.21 |
Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Sell |
Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Buy |
Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 56% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -39.04% since 12/13/22 | +0.15% since 04/19/24 | -2.22% since 04/19/24 | +0.08% since 04/19/24 | -1.91% since 04/19/24 |
Low | 0.0760 on 12/16/22 | 265.72 on 04/26/24 | 65.05 on 04/26/24 | 393.00 on 04/25/24 | 876.75 on 04/25/24 |
High | 0.1439 on 12/14/22 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 |
1-Month | |||||
%Chg | -76.74% since 11/18/22 | -4.41% since 03/26/24 | -9.85% since 03/26/24 | -5.71% since 03/26/24 | -8.70% since 03/26/24 |
Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.05 on 04/26/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
3-Month | |||||
%Chg | -92.75% since 09/20/22 | -13.61% since 01/26/24 | -17.91% since 01/26/24 | -8.27% since 01/26/24 | -6.42% since 01/26/24 |
Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.05 on 04/26/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -93.12% since 06/17/22 | -0.14% since 10/26/23 | -16.84% since 10/26/23 | +9.22% since 10/26/23 | +11.07% since 10/26/23 |
Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 65.05 on 04/26/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 11,770 | 144,488,960 | 81,266,176 | 102,789,152 | 97,762,816 |
Shares Outstanding, K | 144,955 | 536,376 | 1,245,077 | 258,459 | 109,762 |
Annual Sales | 148,760,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
Annual Net Income | -264,520,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
Last Quarter Sales | 30,660,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
60-Month Beta | 0.24 | 0.58 | 0.19 | 0.35 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 29.82 | 24.12 |